Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery

Despite many articles regarding the antihemorrhagic treatment and prophylaxis, there is a lack of experience about how to best conduct major surgical procedures in patients with congenital factor XIII (FXIII) deficiency. Here we report a case of surgery (right inguinal hernia, complicated by heavine...

Full description

Bibliographic Details
Main Authors: Gianluca Sottilotta, Francesca Luise, Vincenzo Oriana, Angela Piromalli, Rosa Santacroce, Alessandra Di Lelio
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Hematology Reports
Subjects:
Online Access:https://www.pagepress.org/journals/index.php/hr/article/view/7912
_version_ 1797935640569970688
author Gianluca Sottilotta
Francesca Luise
Vincenzo Oriana
Angela Piromalli
Rosa Santacroce
Alessandra Di Lelio
author_facet Gianluca Sottilotta
Francesca Luise
Vincenzo Oriana
Angela Piromalli
Rosa Santacroce
Alessandra Di Lelio
author_sort Gianluca Sottilotta
collection DOAJ
description Despite many articles regarding the antihemorrhagic treatment and prophylaxis, there is a lack of experience about how to best conduct major surgical procedures in patients with congenital factor XIII (FXIII) deficiency. Here we report a case of surgery (right inguinal hernia, complicated by heaviness and pain) performed in a patient with FXIII deficiency, receiving recombinant FXIII prophylaxis (Catridecacog 35 UI/kg every 28±2 days). Our experience shows that Catridecacog can be used safely and effectively not only for continued prophylaxis but also in surgery and adds to the very limited body of evidence currently available on surgery in this bleeding disorder.
first_indexed 2024-04-10T18:18:20Z
format Article
id doaj.art-c3214c7de4084157868b569a124706b7
institution Directory Open Access Journal
issn 2038-8322
2038-8330
language English
last_indexed 2024-04-10T18:18:20Z
publishDate 2019-02-01
publisher MDPI AG
record_format Article
series Hematology Reports
spelling doaj.art-c3214c7de4084157868b569a124706b72023-02-02T08:14:45ZengMDPI AGHematology Reports2038-83222038-83302019-02-0111110.4081/hr.2019.7912Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgeryGianluca Sottilotta0Francesca Luise1Vincenzo Oriana2Angela Piromalli3Rosa Santacroce4Alessandra Di Lelio5UOSD Microcitemie – Centro Emofilia – Servizio Emostasi e Trombosi, Grande Ospedale Metropolitano Bianchi- Melacrino-Morelli, Reggio CalabriaUOSD Microcitemie - Centro Emofilia – Servizio Emostasi e Trombosi - Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio CalabriaUOSD Microcitemie - Centro Emofilia – Servizio Emostasi e Trombosi - Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio CalabriaUOSD Microcitemie - Centro Emofilia – Servizio Emostasi e Trombosi - Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio CalabriaServizio di Genetica Medica, Azienda Ospedaliero-Universitaria Ospedali Riuniti di FoggiaCenter for Outcomes Research and Clinical Epidemiology – CORESEARCH, PescaraDespite many articles regarding the antihemorrhagic treatment and prophylaxis, there is a lack of experience about how to best conduct major surgical procedures in patients with congenital factor XIII (FXIII) deficiency. Here we report a case of surgery (right inguinal hernia, complicated by heaviness and pain) performed in a patient with FXIII deficiency, receiving recombinant FXIII prophylaxis (Catridecacog 35 UI/kg every 28±2 days). Our experience shows that Catridecacog can be used safely and effectively not only for continued prophylaxis but also in surgery and adds to the very limited body of evidence currently available on surgery in this bleeding disorder.https://www.pagepress.org/journals/index.php/hr/article/view/7912Recombinant FXIIIcongenital FXIII deficiencysurgery
spellingShingle Gianluca Sottilotta
Francesca Luise
Vincenzo Oriana
Angela Piromalli
Rosa Santacroce
Alessandra Di Lelio
Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery
Hematology Reports
Recombinant FXIII
congenital FXIII deficiency
surgery
title Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery
title_full Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery
title_fullStr Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery
title_full_unstemmed Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery
title_short Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery
title_sort use of catridecacog in a patient with severe factor xiii deficiency undergoing surgery
topic Recombinant FXIII
congenital FXIII deficiency
surgery
url https://www.pagepress.org/journals/index.php/hr/article/view/7912
work_keys_str_mv AT gianlucasottilotta useofcatridecacoginapatientwithseverefactorxiiideficiencyundergoingsurgery
AT francescaluise useofcatridecacoginapatientwithseverefactorxiiideficiencyundergoingsurgery
AT vincenzooriana useofcatridecacoginapatientwithseverefactorxiiideficiencyundergoingsurgery
AT angelapiromalli useofcatridecacoginapatientwithseverefactorxiiideficiencyundergoingsurgery
AT rosasantacroce useofcatridecacoginapatientwithseverefactorxiiideficiencyundergoingsurgery
AT alessandradilelio useofcatridecacoginapatientwithseverefactorxiiideficiencyundergoingsurgery